Cefaxam® 4000/2000 Each vial containing powder holds:

Ceftriaxone Sodium (equiv. to Ceftriaxone).............................................. 4000 mg

Sulbactam Sodium (equiv. to Sulbactam)................................................ 2000 mg

Each vial containing diluent holds:

Sterile diluent ………………………………………………...................................... 10 mL

Cefaxam® is indicated for infections caused by pathogens susceptible to ceftriaxone and sulbactam, including beta-lactamase producers. This combination is indicated for:

- Intra-abdominal infections (peritonitis, biliary tract infections); bone and joint, soft tissue, and skin infections; meningitis; renal and genitourinary tract infections; respiratory tract infections (particularly pneumonia); mastitis; ear, nose, and throat infections; and bacterial septicemia.

- Perioperative infection prophylaxis. A single dose administered prior to surgery minimizes the risk of postoperative infection.

- Complicated infections caused by multidrug-resistant pathogens, including strains producing beta-lactamases and metallo-beta-lactamases.

- Lyme disease (borreliosis) caused by Borrelia burgdorferi.

Cefaxam® is administered by slow intravenous or subcutaneous injection. Add the diluent provided with the product, shake vigorously until the powder is dissolved, and administer immediately. The general dosage is 15 to 50 mg of ceftriaxone + 7.5 to 25 mg of sulbactam per kg of body weight in dogs (once or twice daily), and 25 to 50 mg of ceftriaxone + 12.5 to 25 mg of sulbactam per kg of body weight in cats (twice daily). This is expressed in ml as follows: Dogs: 1 ml/1-3.3 kg and Cats: 1 ml/1-2 kg

Vial with 10 mL diluent + 6 g powder,